Barbas C, Vallejo M, García A, Barlow D, Hanna-Brown M
Facultad de Farmacia, Universidad San Pablo-CEU Madrid, Campus Monteprincipe, Boadilla del Monte, Madrid, Spain.
J Pharm Biomed Anal. 2008 Jun 9;47(2):388-98. doi: 10.1016/j.jpba.2008.01.028. Epub 2008 Jan 20.
The development of an approach by which two CE methods operating with opposite polarities and orthogonal capillary electrophoretic separation modes (method 1: normal polarity cyclodextrin modified MEKC (CD-MEKC) and method 2: reversed polarity CZE) for the sequential application to urinary samples from a type I diabetes metabolomics investigation is discussed. During method development, problematic MEKC profile drift issues arising from the high glucose content of the diabetic animal urine samples required some electrolyte modifications involving the use of hexafluoroisopropanol (HFIP) to circumvent the drift. Data derived from both methods were subsequently subjected to alignment, normalization and multi-dimensional scaling (MDS) procedures. In such a way, classification of samples derived from control and diabetic animals receiving a placebo from those receiving an antioxidant nutraceutical, was successfully demonstrated. Such a strategy is a cost effective and comprehensive metabolomics tool useful for describing UV absorbing metabolite disease-related changes in nutra/pharma-ceutical studies.
本文讨论了一种方法的开发,该方法采用两种具有相反极性和正交毛细管电泳分离模式的CE方法(方法1:正相环糊精修饰的MEKC(CD-MEKC)和方法2:反相CZE),用于对I型糖尿病代谢组学研究中的尿液样本进行顺序分析。在方法开发过程中,糖尿病动物尿液样本中高葡萄糖含量导致的MEKC图谱漂移问题较为棘手,需要对电解质进行一些修改,包括使用六氟异丙醇(HFIP)来避免漂移。随后,对两种方法获得的数据进行了比对、归一化和多维标度(MDS)处理。通过这种方式,成功地将接受安慰剂的对照动物和糖尿病动物样本与接受抗氧化营养保健品的动物样本区分开来。这种策略是一种经济高效且全面的代谢组学工具,可用于描述营养/药物研究中与紫外线吸收代谢物疾病相关的变化。